LCN2 and escherichia coli infection: In the urogenital tract, LCN2 is secreted by urethral mucosa and has been demonstrated to mitigate Escherichia coli infection in bladder epithelial cells by modulating JAK/STAT pathway activation, particularly under hyperglycemic conditions [19,20].